Aerobe provides cutting-edge technology and scientific expertise to support researchers and clinicians in their endeavour to find novel approaches and innovative solutions in a range of disciplines.
We are a goal focused and process driven company, helping us command a high level of professional reputation and goodwill with all our stakeholders.
The LiveAmp is a wearable, 24-bit amplifier – available with 8, 16, 32 and also with 64 channels. As it is wireless and allows you to store your recorded data internally (i.e. on an exchangeable memory card), there are no mobility limitations.
Transcranial Pulse Stimulation (TPS) is a revolutionary new technique that delivers short acoustic pulses with an ultrasound frequency range. The technique allows unprecedented focal brain stimulation reaching depths of as much as 8 cm in the brain. Developed by Storz Medical, the system (NEUROLITH ®) reflects a unparalleled advancement in the field of transcranial stimulation.
The NIRSport 2 is a user-friendly, modular, and robust wireless functional near-infrared spectroscopy (fNIRS) platform which measures hemodynamic responses to neuroactivation via oxy-, deoxy-, and total hemoglobin changes in the cerebral cortex.
The NIRSport 2 comes with a host of ready-to-implement upgrades and modules to meet the needs of a broad range of cognitive neuroscience applications.
The CXS sensor unit (CODA unit) is capable of operating in bright sunlight up to 90,000 Lux.
The CXS combines three motion sensing arrays into one unit. This allows a standalone CXS unit to make a complete 3D measurement without reference to any other units. It also means that the unit can be pre-calibrated and sealed. All the user does is to point the unit at the action.
Designed with user workflow and IT standards in mind, the MYOQUICK EMG-EP system features a color coded Human Interface Device, programmable foot pedal and active handheld stimulator that maximizes efficiency and increases patient comfort.
The Soterix Medical 1×1 was developed by clinical researchers, scientists, and biomedical engineers to provide all clinical standard tDCS protocols. Current intensity from 0.1 to 2 mA (5 mA option available upon request), and current duration from 5 to 40 minutes. Stimulation set-up is straight-forward with the simple to set-up Open-Panel™ controls, 1×1 electrode accessories, and SmartScan™ indicator. The tDCS 1×1 features allow you to focus on the subject and experiment, not the device.
Medoc Q-Sense is a portable, easy-to-use and affordable quantitative sensory testing (QST) device for clinical, research and pharmacologic trial use.
Q-Sense offers scientifically validated measures of warm, cool and heat-pain thermal sensory thresholds. All of these can be useful determinants in the evaluation of peripheral sensory nerve function, neuropathic pain, diabetic, chemotherapeutic, and other small-fiber neuropathies.
The EyeBrain T2 is a medical device measuring eye and head movements.
It was designed to assist in the diagnosis of neurological and psychiatric diseases and reading disorders.
Severals test are available to assess parameters as latency, speed and precision during saccads.
The EyeBrain Trackers innovate by enabling patient test results to be compared to normative values in the same way as a blood test.
With its slim design, high definition 40” display and superior picture quality, the InroomViewingDevice is the optimal choice for an easy-to-use alternative to conventional projectors or goggle-based image delivery systems.
This is the ideal tool to provide images or video inside the MRI scan room.
We are committed to provide the best Customer Support in the Industry. A sale is not an end, rather it is a beginning of a relationship for Aerobe. We believe that a satisfied customer is the best Sales reference.
Facts about us-
BESA Connectivity 2.0 is now released. Experience the un-matched combination of state-of-the-art technology and superior ease-of-use, paired with top-of-the range visualization options! Applying these to your data will help you reveal the brain connectivity related to your experiment.
HD-Targets-IFS: A new targeting feature for Interferential Stimulation (IFS) / Temporal Interference (TI) Stimulation using the MNI 152 head model. Choose from a list of brain targets based on the human connectome parcellation scheme to obtain an optimized HD-IFS configuration.
Transcranial Pulse Stimulation (TPS) uses shockwaves for the treatment of Alzheimer´s patients. Recently, our group published short-term clinical results after the first treatment cycle (Cont et al. 2022). However, many aspects remain unclear concerning patient selection and treatment protocols.
Keynotes from leading experts in the field: David Mehler, MD, PhD (Applied Computational Neuroscience (ACN) lab at the Uniklinik RWTH Aachen and Lucas R. Trambaiolli, PhD (Research Fellow in Psychiatry, McLean Hospital, Harvard Medical School)
The safety of research participants is the main concern for simultaneous EEG-fMRI acquisitions. We also aim to protect the BrainAmp MR system from damage within the harsh MR environment. This support tip explains the factors in the MR environment that make the BrainAmp MR (EEG/ExG) amplifiers and Powerpacks vulnerable to heating. We also provide recommendations on how to minimize the risk of heating and damage.
Using naturalistic paradigms and stimuli is becoming increasingly prominent in cognitive neuroscience, where experimentation beyond the lab is increasingly possible. Studying the human brain in its ‘natural habitat’ provides ecological validity to our theories and promises novel insights into complex cognitive functioning. This relies on emerging technologies to take research out of the lab and into the wild, and combining these techniques offers a toolkit to study neural function in uncontrolled complex environments. We present and validate such an approach, through studying face processing in naturalistic, real-world environments, while importantly retaining the ability to manipulate our visual perceptions.
Simpler key layouts and customizable keys mean no frustration for participants and less time spent searching for the correct key, yielding better reaction times (RTs). We built the electronics and matching software from the ground up for better timing.
Alzheimer’s disease (AD) is a very common cause of dementia in many countries all over the world and a common cause of death in elderly humans. No effective long-term treatment has been found yet.
Harald Bornfleth: “Products that never stand still. On the product side, the focus is clearly on the release of BESA Connectivity 2.0. Users can look forward to the latest methods for calculating brain connectivity and a unique, user-friendly operability. The topic is already highly complex. It is all the more important that users can quickly get an idea of the various aspects of connectivity. Our new release scheduled for April 2023 will make this possible. Furthermore, we are working on a successor to our core product BESA Research.
In a recent study from Aalborg University in Denmark the effect of oxaliplatin on nerve function has been prospectively assessed throughout the treatment course. Patients (n=17) with Stage III colon cancer, but otherwise healthy, were tested before commencement of oxaliplatin-adjuvant chemotherapy, and prior to each new cycle.
Visual stimuli consisted of a face pictures. Pictures of a neutral stranger’s face, a stranger’s happy face or a stranger’s angry face taken from the Karolinska Directed Emotional Faces photo collection. The participants were also shown picture of their partner’s neutral face. Control pictures of an innate object were used, originating from the International Affective Picture System.
Alzheimer”s disease (AD) is considered to be a progressive irreversible illness. So far an effective treatment of symptoms in Alzheimer”s disease has not yet been found. One of the symptoms often found in AD patients is the significant reduction of executive functions. Furthermore” affective fluctuations and depressive moods occur regularly. Transcranial pulse stimulation (TPS) induced by shock waves which were individually navigated according to current MRI-scans induced an amelioration of executive functions and reductions of depressive symptoms in patients with AD.
BESA Connectivity 2.0 is now released. Experience the un-matched combination of state-of-the-art technology and superior ease-of-use, paired with top-of-the range visualization options! Applying these to your data will help you reveal the brain connectivity related to your experiment.
The safety of research participants is the main concern for simultaneous EEG-fMRI acquisitions. We also aim to protect the BrainAmp MR system from damage within the harsh MR environment. This support tip explains the factors in the MR environment that make the BrainAmp MR (EEG/ExG) amplifiers and Powerpacks vulnerable to heating. We also provide recommendations on how to minimize the risk of heating and damage.
Using naturalistic paradigms and stimuli is becoming increasingly prominent in cognitive neuroscience, where experimentation beyond the lab is increasingly possible. Studying the human brain in its ‘natural habitat’ provides ecological validity to our theories and promises novel insights into complex cognitive functioning. This relies on emerging technologies to take research out of the lab and into the wild, and combining these techniques offers a toolkit to study neural function in uncontrolled complex environments. We present and validate such an approach, through studying face processing in naturalistic, real-world environments, while importantly retaining the ability to manipulate our visual perceptions.
HD-Targets-IFS: A new targeting feature for Interferential Stimulation (IFS) / Temporal Interference (TI) Stimulation using the MNI 152 head model. Choose from a list of brain targets based on the human connectome parcellation scheme to obtain an optimized HD-IFS configuration.
It has been designed with a new REVERSE layout to meet the requirements coming from the market where the reverse layout is required and can be used for clinical routine EEG in wireless modein combination with SD LTM PLUS amplifier.
We are happy to announce the new SyncBox Scanner Interface Duo. The SyncBox is used to synchronize the sampling rate of the BrainAmp MR amplifier with the MR scanner clock system. In brief, the aim is to achieve phase locking between the two clock systems to facilitate optimum correction of scanner-related artifacts in the EEG data. This is essential for achieving the best EEG-fMRI data quality. The SyncBox system comprises the SyncBox Main Unit and the SyncBox Scanner Interface. The Main Unit distributes the sync signal to the BrainAmp USB 2 Adapter (BUA), which drives the sampling frequency, and also to the computer to allow online synchronization validation. Whereas, the Scanner Interface galvanically isolates the Main Unit from the MR scanner to prevent any impact on the scanner clock system.
Keynotes from leading experts in the field: David Mehler, MD, PhD (Applied Computational Neuroscience (ACN) lab at the Uniklinik RWTH Aachen and Lucas R. Trambaiolli, PhD (Research Fellow in Psychiatry, McLean Hospital, Harvard Medical School)
In this two-day workshop in Singapore we will give an introduction to EEG analysis methods using Analyzer 2. The workshop will give a comprehensive introduction to the Analyzer 2 software followed by lectures and hands-on data analysis sessions covering data processing steps such as preprocessing, artifact handling, event related potential analysis, and spectral analysis. This event is intended for researchers who are new to EEG & Analyzer 2 as well as more experienced researchers looking for useful tips.
The first day will cover the nature of the EEG signal, how to acquire an EEG signal, and how to optimize your recording setup. Then, days 2-4 will focus on EEG analysis with BrainVision Analyzer. We will cover all major EEG analysis methods in Analyzer. Learn more and get your tickets to this in-person hands-on workshop.
Transcranial Pulse Stimulation (TPS) uses shockwaves for the treatment of Alzheimer´s patients. Recently, our group published short-term clinical results after the first treatment cycle (Cont et al. 2022). However, many aspects remain unclear concerning patient selection and treatment protocols.
Alzheimer’s disease (AD) is a very common cause of dementia in many countries all over the world and a common cause of death in elderly humans. No effective long-term treatment has been found yet.
Alzheimer”s disease (AD) is considered to be a progressive irreversible illness. So far an effective treatment of symptoms in Alzheimer”s disease has not yet been found. One of the symptoms often found in AD patients is the significant reduction of executive functions. Furthermore” affective fluctuations and depressive moods occur regularly. Transcranial pulse stimulation (TPS) induced by shock waves which were individually navigated according to current MRI-scans induced an amelioration of executive functions and reductions of depressive symptoms in patients with AD.
We provide solutions for healthcare and research. We distribute medical equipment, provide scientific expertise and support to researcher
© 2020 Aerobe. All Rights Reserved Terms & Conditions | Privacy Policy